Cost effectiveness of chemoprevention for prostate cancer with dutasteride in a high-risk population based on results from the REDUCE clinical trial

Michael W. Kattan, Stephanie R. Earnshaw, Cheryl L. McDade, Libby K. Black, Gerald L. Andriole

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Cost effectiveness of chemoprevention for prostate cancer with dutasteride in a high-risk population based on results from the REDUCE clinical trial'. Together they form a unique fingerprint.

Business & Economics

Medicine & Life Sciences

Social Sciences